Hoffmann-La Roche Ltd. regulatory update

Roche's Xenical (orlistat) to treat obesity will be reviewed on May 14 by the FDA's Endocrinologic and Metabolic Drugs Advisory Committee. Xenical, which blocks the absorption of fat from the diet, h...